INCB106385

· Incyte Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCB106385, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]